Drug Discovery Solutions

  1. SUREmAb — Monoclonal Antibody Development, The Way It's Meant To Be 8/4/2023

    Leverage robust development strategies and enable an optimized process for mAb development and manufacturing, efficiency and speed with exceptional quality, and high titers with lower-cost workflows for maximum ROI.

  2. Protein Degraders: From Discovery To Development 11/18/2025

    Leverage integrated platforms for targeted protein degradation and molecular glue solutions, from ligand identification to IND-enabling studies. Advanced screening and structural biology support accelerate discovery.

  3. ADCs: From Design To Development 1/4/2024

    Explore how a CDMO with specialized teams can support running different stages in parallel to facilitate data sharing and clear communication, ultimately taking your ADC from design to development.

  4. LV Edge System 11/24/2025

    By transitioning from a 4-plasmid transient system to 1- or 0-plasmid configurations, the LV Edge systems reduce or eliminate the need for GMP plasmids, lowering costs and supply chain risks.

  5. Research And Development Services For Gene Therapies 9/16/2025

    Our mission is clear: to help sponsors reduce costs, shorten timelines, and de-risk development, so they can achieve critical milestones, secure investments, and advance life-changing therapies.

  6. Pharma Services Fill, Finish & Drug Delivery CDMO 11/7/2025

    Sterile fill-finish and device assembly capabilities span global sites, offering scalable solutions, analytical testing, and regulatory compliance for combination products and small-batch technical programs.

  7. Monoclonal Antibodies & Antibody-Drug Conjugates 2/18/2026

    A clear overview of analytical solutions for mAbs and ADCs, covering structural characterization, potency, genetic QC, stability, and biosafety. Learn how comprehensive testing supports safer, more consistent biologics from early development through commercial release.

  8. iPSC Generation Services 9/30/2025

    iPSC generation is a complex process of reprogramming adult somatic cells into a pluripotent, embryonic stem cell-like stage.

  9. NanoAssemblr® Spark™: Freedom To Discover 4/14/2022

    The NanoAssemblr® Spark™ is ideal for nanomedicine formulation discovery and screening at microliter scales.

  10. Discover Our iPSC Differentiated Cell Services 9/30/2025

    iPSC-differentiated cell lines combine scalability and biorelevance, enabling precise disease modeling, drug screening, and regenerative research with customizable lineage-specific differentiation options.